Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vivistim Registry for Paired VNS Therapy (GRASP)

NCT: NCT05301140 · RECRUITING

NCT IDNCT05301140
StatusRECRUITING
Start Date2023-03-15
Completion2028-12-31

Brief Summary

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.

Frequently Asked Questions

What is Vivistim Registry for Paired VNS Therapy (GRASP)?

Vivistim Registry for Paired VNS Therapy (GRASP) is a clinical trial registered under NCT05301140. Current status: RECRUITING.

What is the status of NCT05301140?

The current status of NCT05301140 (Vivistim Registry for Paired VNS Therapy (GRASP)) is: RECRUITING.

When did Vivistim Registry for Paired VNS Therapy (GRASP) start?

Vivistim Registry for Paired VNS Therapy (GRASP) started on 2023-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.